{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:14:22Z","timestamp":1777724062021,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.biopha.2006.07.008","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T17:44:58Z","timestamp":1154540698000},"page":"409-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Role of\u00a018F-FDG-PET and\u00a0PET\/CT imaging in\u00a0thyroid cancer"],"prefix":"10.1016","volume":"60","author":[{"given":"Cristina","family":"Nanni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Farsad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Rampin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Banti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Carpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Muzzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2006.07.008_bib1","first-page":"33","article-title":"Global cancer statistics","volume":"49","author":"Parkin","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2006.07.008_bib2","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base Report on 53,856 cases of thyroid carcinoma treated in the US, \u201885\u201395\u2019","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2006.07.008_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1097-0142(19950101)75:1+<338::AID-CNCR2820751316>3.0.CO;2-F","article-title":"Endocrine gland cancer","volume":"75","author":"Correa","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2006.07.008_bib4","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, \u201885\u201395\u2019","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2006.07.008_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/thy.1994.4.233","article-title":"The demise of follicular carcinoma of the thyroid gland","volume":"4","author":"LiVolsi","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2006.07.008_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0889-8529(18)30311-6","article-title":"Follicular and H\u00fcrthle cell carcinoma of the thyroid","volume":"19","author":"Cooper","year":"1990","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.biopha.2006.07.008_bib7","first-page":"362","article-title":"Dose\u2013response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid","volume":"77","author":"Schneider","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2006.07.008_bib8","first-page":"1","article-title":"A population based case\u2013control study of thyroid cancer","volume":"79","author":"Ron","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2006.07.008_bib9","series-title":"Cancer\u2014principles and practice of oncology. 5th ed","first-page":"1629","article-title":"Thyroid tumors","author":"Fraker","year":"1997"},{"key":"10.1016\/j.biopha.2006.07.008_bib10","first-page":"285","article-title":"Perspective: National Cancer Institute summary about estimated exposures and thyroid doses received from iodine-131 in fallout after Nevada atmospheric nuclear bomb tests","volume":"48","author":"Hundahl","year":"1998","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2006.07.008_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.1987.03400050071030","article-title":"Thyroid neoplasia in Marshall islanders exposed to nuclear fallout","volume":"258","author":"Hamilton","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2006.07.008_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(19940715)74:2<748::AID-CNCR2820740231>3.0.CO;2-H","article-title":"Pediatric thyroid cancer after the Chernobyl disaster","volume":"74","author":"Nikiforov","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2006.07.008_bib13","series-title":"Cancer epidemiology and prevention","first-page":"1000","article-title":"Thyroid cancer","author":"Ron","year":"1996"},{"key":"10.1016\/j.biopha.2006.07.008_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.1995.5.407","article-title":"Medullary thyroid carcinoma: recent advances and management update","volume":"5","author":"Marsh","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2006.07.008_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2165\/00003495-199855060-00007","article-title":"Drug therapy alternatives in the treatment of thyroid cancer","volume":"55","author":"O\u2019Doherty","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2006.07.008_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00003072-198803000-00003","article-title":"New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma","volume":"13","author":"Hoefnagel","year":"1988","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib17","first-page":"334","article-title":"Role of 131-I metaiodobenzylguanidine therapy in medullary thyroid carcinoma","volume":"35","author":"Hoefnagel","year":"1991","journal-title":"J. Nucl. Biol. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/bjc.1994.224","article-title":"Selective venous sampling catheterization for localization of persisting medullary thyroid carcinoma","volume":"69","author":"Abdelmoumene","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2006.07.008_bib19","series-title":"Textbook of endocrine surgery","first-page":"127","article-title":"Anaplastic carcinoma of the thyroid gland","author":"Rosen","year":"1997"},{"key":"10.1016\/j.biopha.2006.07.008_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0142(197207)30:1<113::AID-CNCR2820300118>3.0.CO;2-E","article-title":"Anaplastic spindle-cell and giant-cell tumors of the thyroid gland","volume":"30","author":"Nishiyama","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2006.07.008_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2006.07.008_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/thy.1997.7.327","article-title":"Comparison of F-18 FDG-PET with iodine-131 and Tc-99m-sestamibi scintigraphy in differentiated thyroid cancer","volume":"7","author":"Grunwald","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2006.07.008_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00837630","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer","volume":"23","author":"Grunwald","year":"1996","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib24","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/jcem.84.7.5827","article-title":"[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels","volume":"84","author":"Wang","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2006.07.008_bib25","first-page":"1843","article-title":"Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99mpertechnetate and iodine-131-sodium iodide","volume":"36","author":"Scott","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib26","first-page":"986","article-title":"Value of FDG PET in papillary thyroid carcinoma with negative I-131 whole-body scan","volume":"40","author":"Chung","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib27","first-page":"1468","article-title":"Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer","volume":"37","author":"Feine","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib28","first-page":"616","article-title":"Integrated PET\/CT in differentiated thyroid cancer. Diagnostic Accuracy and Impact on Patient Management","volume":"47","author":"Holger","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib29","first-page":"1090","article-title":"Uptake of 18-fluoro-2-deoxy-Dglucose by thyroid cancer: implications for diagnosis and therapy","volume":"77","author":"Sisson","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2006.07.008_bib30","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s002590050158","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer","volume":"24","author":"Dietlein","year":"1997","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib31","first-page":"770","article-title":"18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results","volume":"47","author":"de Geus-Oei","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib32","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.surg.2005.08.031","article-title":"Preoperative evaluation of thyroid nodules with 18F-FDG-PET\/CT","volume":"138","author":"Mitchell","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.biopha.2006.07.008_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1563-2571.2003.02045.x","article-title":"Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET\/CT scanner","volume":"30","author":"Bockisch","year":"2003","journal-title":"Acta Med. Austriaca"},{"key":"10.1016\/j.biopha.2006.07.008_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1067\/mhn.2003.74","article-title":"Combined positron emission tomography\/computed tomography imaging of recurrent thyroid cancer","volume":"128","author":"Zimmer","year":"2003","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.biopha.2006.07.008_bib35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0003-4975(94)91091-X","article-title":"Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer","volume":"58","author":"Bollen","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.biopha.2006.07.008_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0038-1629837","article-title":"PET imaging of recurrent medullary thyroid cancer","volume":"35","author":"Simon","year":"1996","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.biopha.2006.07.008_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002590050533","article-title":"The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer","volume":"27","author":"Brandt-Mainz","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF03348014","article-title":"Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma","volume":"20","author":"Gasparoni","year":"1997","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.biopha.2006.07.008_bib39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0039-6060(97)90208-7","article-title":"Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study","volume":"122","author":"Musholt","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.biopha.2006.07.008_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","article-title":"Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours","volume":"25","author":"Adams","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib41","first-page":"66","article-title":"18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma","volume":"43","author":"Szakall","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2006.07.008_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1095-0397(99)00014-X","article-title":"Evaluation of rare tumors with [F-18]fluorodeoxyglucose positron emission tomography","volume":"2","author":"Jadvar","year":"1999","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.biopha.2006.07.008_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/thy.1999.9.797","article-title":"Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography","volume":"9","author":"Conti","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2006.07.008_bib44","unstructured":"McDougall IR, Jadvar H, Segall G. PET scan in patients with suspected recurrent thyroid cancer. Presented at Thyroid One. Thyroid Cancer Pathogenesis, Diagnosis including PET, and Treatment. International Symposium. October 7\u201310, 1998, Linz, Austria. Thyroid 1998;1222 pp. 134\u2013147."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332206001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332206001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:37:47Z","timestamp":1760092667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332206001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0753332206001314"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2006.07.008","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of\u00a018F-FDG-PET and\u00a0PET\/CT imaging in\u00a0thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2006.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}